{"content":"<li class=\"n-box-item date-title\" data-end=\"1479790799\" data-start=\"1479704400\" data-txt=\"Sunday, December 22, 2019\">Monday, November 21, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3226238\" data-ts=\"1479770111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTE\" target=\"_blank\">GTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226238-gran-tierra-energy-to-sell-43_3m-shares-in-bought-deal-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gran Tierra Energy to sell 43.3M shares in bought deal offering</a></h4><ul>     <li>Gran Tierra Energy (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/GTE\" title=\"Gran Tierra Energy, Inc\">GTE</a>) <font color=\"red\">-5.3%</font> AH after announcing plans to sell more than 43.3M shares on a bought deal basis at $3/share, with an underwriters option to purchase up to another 6.5M-plus common shares; if the over-allotment option is exercised in full, gross proceeds from the offering would total nearly $150M.</li>     <li>GTE says it plans to use the proceeds to repay borrowings outstanding under its revolving credit facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226238\" data-linked=\"Gran Tierra Energy to sell 43.3M shares in bought deal offering\" data-tweet=\"$GTE - Gran Tierra Energy to sell 43.3M shares in bought deal offering https://seekingalpha.com/news/3226238-gran-tierra-energy-to-sell-43_3m-shares-in-bought-deal-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3226238-gran-tierra-energy-to-sell-43_3m-shares-in-bought-deal-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226233\" data-ts=\"1479768311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226233-proofpoint-fireeye-fortinet-cyberark-software-down-after-hours-subsequent-palo-alto-networks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint, FireEye, Fortinet, CyberArk Software down after hours subsequent Palo Alto Networks Q1 reporting</a></h4><ul>\n<li>Proofpoint's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PFPT\" title=\"Proofpoint, Inc.\">PFPT</a>) at present <font color=\"red\">lower by nearly 4%</font>, FireEye (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FEYE\" title=\"FireEye, Inc.\">FEYE</a>) and Fortinet (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FTNT\" title=\"Fortinet, Inc.\">FTNT</a>) <font color=\"red\">2%</font>, and CyberArk Software (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYBR\" title=\"CyberArk Software Ltd.\">CYBR</a>) <font color=\"red\">1.15%</font>.</li>\n<li>Names in the sector unchanged include Check Point Software Technologies, Imperva, Symantec, Barracuda Networks and VASCO Data Security International, though trading in both Check Point Software Technologies and Barracuda Networks is relatively active.</li>\n<li>Earlier: <a href=\"https://seekingalpha.com/news/3226191-palo-alto-networks-minus-13_8-percent-q1-actual-q2-guide-revenue-expectations\" target=\"_blank\">Palo Alto Networks -13.8%; Q1 actual, Q2 guide off revenue expectations</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226233\" data-linked=\"Proofpoint, FireEye, Fortinet, CyberArk Software down after hours subsequent Palo Alto Networks Q1 reporting\" data-tweet=\"$PFPT $PFPT $FEYE - Proofpoint, FireEye, Fortinet, CyberArk Software down after hours subsequent Palo Alto Networks Q1 reporting https://seekingalpha.com/news/3226233-proofpoint-fireeye-fortinet-cyberark-software-down-after-hours-subsequent-palo-alto-networks?source=tweet\" data-url=\"https://seekingalpha.com/news/3226233-proofpoint-fireeye-fortinet-cyberark-software-down-after-hours-subsequent-palo-alto-networks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226231\" data-ts=\"1479768180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226231-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/SBLK\" title=\"Star Bulk Carriers Corp.\">SBLK</a> <font color=\"green\">+9.3%</font>. <a href=\"https://seekingalpha.com/symbol/ENTA\" title=\"Enanta Pharmaceuticals, Inc.\">ENTA</a> <font color=\"green\">+3.1%</font>. <a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"green\">+3.0%</font>. <a href=\"https://seekingalpha.com/symbol/WLL\" title=\"Whiting Petroleum Corporation\">WLL</a> <font color=\"green\">+2.3%</font>. <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"green\">+2.2%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a> <font color=\"red\">-11.8%</font>. <a href=\"https://seekingalpha.com/symbol/DY\" title=\"Dycom Industries Inc.\">DY</a> <font color=\"red\">-9.6%</font>. <a href=\"https://seekingalpha.com/symbol/BECN\" title=\"Beacon Roofing Supply, Inc.\">BECN</a> <font color=\"red\">-7.6%</font>. <a href=\"https://seekingalpha.com/symbol/PNNT\" title=\"PennantPark Investment\">PNNT</a> <font color=\"red\">-7.5%</font>. <a href=\"https://seekingalpha.com/symbol/VIPS\" title=\"Vipshop Holdings\">VIPS</a> <font color=\"red\">-7.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226231\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SBLK $ENTA $SINA - After Hours Gainers / Losers https://seekingalpha.com/news/3226231-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3226231-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226220\" data-ts=\"1479766126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226220-cti-biopharma-perks-up-on-presentation-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CTI BioPharma perks up on presentation announcement</a></h4><ul>\n<li>In a late-breaking oral presentation at the American Society of Hematology annual meeting Dec. 3-6, CTI BioPharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a>) will disclose data from its Phase 3 PERSIST-2 trial for comparing the investigational agent pacritinib, an oral multikinase inhibitor, with physician-specified best available therapy, including ruxolitinib, for treatment of patients with myelofibrosis whose baseline platelet counts are less than 100,000 per microliter.</li>\n<li>Share are <font color=\"green\">higher by 15%</font> in thin after hours action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226220\" data-linked=\"CTI BioPharma perks up on presentation announcement\" data-tweet=\"$CTIC - CTI BioPharma perks up on presentation announcement https://seekingalpha.com/news/3226220-cti-biopharma-perks-up-on-presentation-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3226220-cti-biopharma-perks-up-on-presentation-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226214\" data-ts=\"1479765552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIGP\" target=\"_blank\">RIGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226214-transocean-improves-acquisition-offer-for-transocean-partners\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean improves acquisition offer for Transocean Partners</a></h4><ul>\n<li>Transocean Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/RIGP\" title=\"Transocean Partners LLC\">RIGP</a>) <font color=\"green\">+6.8%</font> AH after Transocean (NYSE:<a href=\"https://seekingalpha.com/symbol/RIG\" title=\"Transocean Ltd.\">RIG</a>) says it will <a href=\"https://www.sec.gov/Archives/edgar/data/1607250/000155837016010213/rigp_currentfolio8k.htm\" target=\"_blank\">increase to 1.2 shares</a> from 1.1427 the consideration for its pending acquisition of each RIGP common unit it does not already own.</li>\n<li>The move follows the recent <a href=\"https://seekingalpha.com/article/4023410-can-transocean-transocean-partners-merger-fail\" target=\"_blank\">failure</a> to receive 50.1% of shareholder votes necessary to approve the RIG-RIGP merger.</li>\n<li>RIG expects to issue ~23.8M shares in the merger.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226214\" data-linked=\"Transocean improves acquisition offer for Transocean Partners\" data-tweet=\"$RIGP $RIGP $RIG - Transocean improves acquisition offer for Transocean Partners https://seekingalpha.com/news/3226214-transocean-improves-acquisition-offer-for-transocean-partners?source=tweet\" data-url=\"https://seekingalpha.com/news/3226214-transocean-improves-acquisition-offer-for-transocean-partners\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226213\" data-ts=\"1479765401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BFAM\" target=\"_blank\">BFAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226213-bright-horizons-insiders-cash-in-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bright Horizons insiders cash in some stock</a></h4><ul>\n<li>The company announces a secondary offering of 2M shares from selling shareholders. Bright Horizons (NYSE:<a href=\"https://seekingalpha.com/symbol/BFAM\" title=\"Bright Horizons Family Solutions, Inc.\">BFAM</a>) will receive no proceeds.</li>\n<li>Shares <font color=\"red\">-1.9%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226213\" data-linked=\"Bright Horizons insiders cash in some stock\" data-tweet=\"$BFAM - Bright Horizons insiders cash in some stock https://seekingalpha.com/news/3226213-bright-horizons-insiders-cash-in-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3226213-bright-horizons-insiders-cash-in-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226212\" data-ts=\"1479764985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPP\" target=\"_blank\">HPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226212-hudson-pacific-lower-blackstone-sells\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson Pacific lower as Blackstone sells more</a></h4><ul>\n<li>The secondary size is 18.7M shares, and consists of 17.5M shares offered by Hudson Pacific (NYSE:<a href=\"https://seekingalpha.com/symbol/HPP\" title=\"Hudson Pacific Properties, Inc.\">HPP</a>) and 1.17M shares by Farallon Capital Management.</li>\n<li>Proceeds will be used to buy back 17.25M units in the operating partnership mostly being offered by Blackstone.</li>\n<li>After the deal, Blackstone will own about 11.8% of the company, and Farallon 1%.</li>\n<li>HPP<font color=\"red\"> down 2.2%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226212\" data-linked=\"Hudson Pacific lower as Blackstone sells more\" data-tweet=\"$HPP - Hudson Pacific lower as Blackstone sells more https://seekingalpha.com/news/3226212-hudson-pacific-lower-blackstone-sells?source=tweet\" data-url=\"https://seekingalpha.com/news/3226212-hudson-pacific-lower-blackstone-sells\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226207\" data-ts=\"1479764379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNNT\" target=\"_blank\">PNNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226207-pennantpark-tumbles-after-rough-quarter-dividend-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PennantPark tumbles after rough quarter, dividend cut</a></h4><ul>\n<li>Noting continued weakness in energy and \"overall yield compression in the market,\" PennantPark (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PNNT\" title=\"PennantPark Investment\">PNNT</a>) says it will pay out the expected $0.28 per share this quarter, but then cut the dividend to $0.18 beginning in the March quarter.</li>\n<li>Management will extend its 16% waiver of base and incentive fees through the end of next year.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3226189-pennantpark-investment-misses-0_05\" target=\"_blank\">PennantPark Investment misses by $0.05</a> (Nov. 21)</li>\n<li>Shares<font color=\"red\"> -10%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226207\" data-linked=\"PennantPark tumbles after rough quarter, dividend cut\" data-tweet=\"$PNNT - PennantPark tumbles after rough quarter, dividend cut https://seekingalpha.com/news/3226207-pennantpark-tumbles-after-rough-quarter-dividend-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3226207-pennantpark-tumbles-after-rough-quarter-dividend-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226202\" data-ts=\"1479764008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WB\" target=\"_blank\">WB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226202-weibo-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weibo beats by $0.04, beats on revenue</a></h4><ul>\n<li>Weibo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WB\" title=\"Weibo Corporation\">WB</a>): Q3 EPS of $0.24 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $176.9M (+41.8% Y/Y) <font color=\"green\">beats by $3.83M</font>.</li>\n<li>Shares <font color=\"green\">+2.5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226202\" data-linked=\"Weibo beats by $0.04, beats on revenue\" data-tweet=\"$WB - Weibo beats by $0.04, beats on revenue https://seekingalpha.com/news/3226202-weibo-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3226202-weibo-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226200\" data-ts=\"1479763970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDGE\" target=\"_blank\">BDGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226200-capital-raise-for-bridge-bancorp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital raise for Bridge Bancorp</a></h4><ul>\n<li>The Bridgehampton lender is using the occasion of the recent run-up in its stock price to sell some shares - about $50M worth, with an underwriter greenshoe of up to another 15% of the number sold.</li>\n<li>The underwriters are Sandler O'Neill and KBW.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/BDGE\" title=\"Bridge Bancorp, Inc.\">BDGE</a><font color=\"red\"> -1.9%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226200\" data-linked=\"Capital raise for Bridge Bancorp\" data-tweet=\"$BDGE - Capital raise for Bridge Bancorp https://seekingalpha.com/news/3226200-capital-raise-for-bridge-bancorp?source=tweet\" data-url=\"https://seekingalpha.com/news/3226200-capital-raise-for-bridge-bancorp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226191\" data-ts=\"1479763382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226191-palo-alto-networksminus-13_8-q1-actual-q2-guide-off-revenue-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks -13.8%; Q1 actual, Q2 guide off revenue expectations</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3226175-palo-alto-networks-beats-0_02-misses-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $398.1M (+34% Y/Y, <font color=\"red\">$2.1M below estimates</font>), EPS $0.55 (<font color=\"green\">$0.02 above estimates</font>), net income $51.2M (vs. $30.8M Y/Y), cash flow from operations $203.3M (+39% Y/Y), free cash flow $182.4M (+43% Y/Y),</li>\n<li>\n<strong>Highlight metrics</strong> \u2013 billings $516.9M (+33% Y/Y), deferred revenue $1.4B (+69% Y/Y), 1,500 new customers added</li>\n<li>\n<strong>Q2 projections</strong> \u2013 revenue $426M-$432M (+27%-29% Y/Y increase) [<a href=\"https://finance.yahoo.com/quote/PANW/analysts?p=PANW\" target=\"_blank\">consensus $438.88M</a>], EPS $0.61-$0.63 (consensus $0.63)</li>\n<li>Palo Alto Networks (NYSE:<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a>) CEO Mark McLaughlin: \"Our first quarter 2017 results underscore that our Next-Generation Security Platform uniquely solves customers' most complex security challenges. Our platform's ability to provide high degrees of prevention, automation, leverage and consistent security, regardless of wherever data may be, is becoming increasingly important in the face of today's important macro technology changes. As a result, customers and prospects globally are adopting our platform at high rates.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/PANW/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/ofw5pocp/lan/en\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226191\" data-linked=\"Palo Alto Networks -13.8%; Q1 actual, Q2 guide off revenue expectations\" data-tweet=\"$PANW - Palo Alto Networks -13.8%; Q1 actual, Q2 guide off revenue expectations https://seekingalpha.com/news/3226191-palo-alto-networksminus-13_8-q1-actual-q2-guide-off-revenue-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3226191-palo-alto-networksminus-13_8-q1-actual-q2-guide-off-revenue-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226177\" data-ts=\"1479762359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226177-jack-in-box-beats-0_15-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jack In The Box beats by $0.15,  revenue in-line</a></h4><ul>\n<li>Jack In The Box (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JACK\" title=\"Jack In The Box Inc.\">JACK</a>): FQ4 EPS of $1.03 <font color=\"green\">beats by $0.15</font>.</li>\n<li>Revenue of $398.42M (+12.5% Y/Y) in-line.</li>\n<li>Shares <font color=\"green\">+1.35%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226177\" data-linked=\"Jack In The Box beats by $0.15,  revenue in-line\" data-tweet=\"$JACK - Jack In The Box beats by $0.15, revenue in-line https://seekingalpha.com/news/3226177-jack-in-box-beats-0_15-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3226177-jack-in-box-beats-0_15-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226174\" data-ts=\"1479761926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226174-landslide-kills-13-illegal-diggers-invade-freeports-temke-mine-in-congo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Landslide kills 13 as illegal diggers invade Freeport&#39;s Temke mine in Congo</a></h4><ul>     <li>A landslide <a href=\"http://www.reuters.com/article/us-congo-mining-idUSKBN13G1WA\" target=\"_blank\">killed at least 13 people last week</a> in the Democratic Republic of Congo after thousands of artisanal miners began invading Freeport McMoRan's (<a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"green\">+5.6%</font>) Temke copper mine, according to the Lualaba provincial governor.</li>     <li>Between 5K-10K illegal miners have descended on the Tenke copper mine, one of the world's largest, in the past week for reasons that are not entirely clear.</li>     <li>Tens of thousands of people in the area depend on small-scale mining to support their families and often operate within the perimeters of industrial mines, using rudimentary tools, sometimes resulting in deadly accidents.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226174\" data-linked=\"Landslide kills 13 as illegal diggers invade Freeport&#39;s Temke mine in Congo\" data-tweet=\"$FCX - Landslide kills 13 as illegal diggers invade Freeport&#39;s Temke mine in Congo https://seekingalpha.com/news/3226174-landslide-kills-13-illegal-diggers-invade-freeports-temke-mine-in-congo?source=tweet\" data-url=\"https://seekingalpha.com/news/3226174-landslide-kills-13-illegal-diggers-invade-freeports-temke-mine-in-congo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226165\" data-ts=\"1479761897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226165-s-and-p-global-rates-symantec-bbb-places-on-creditwatch-negative-implications-following\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P Global rates Symantec BBB-, places on CreditWatch with negative implications following LifeLock acquisition</a></h4><ul><li><a href=\"http://www.streetinsider.com/Credit+Ratings/Symantec+%28SYMC%29+Ratings+Placed+on+CreditWatch+Negative+by+S%26P/12271769.html\" target=\"_blank\">Attributed to</a> Symantec's (<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color='green'>+3.2%</font>) planned funding of its <a href=\"https://seekingalpha.com/news/3225931-symantec-buy-lifelock-2_3b\" target=\"_blank\">$2.3B buyout of LifeLock</a> with $1.5B of balance sheet cash and $750M of incremental debt.</li><li>S&amp;P Global Ratings expects increased debt and lower levels of cash to bring adjusted leverage to more than 4x at transaction finalization and to remain greater than 3x for 12-24 months subsequent that point.</li><li>A more than two-notch downgrade is considered unlikely.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226165\" data-linked=\"S&amp;P Global rates Symantec BBB-, places on CreditWatch with negative implications following LifeLock acquisition\" data-tweet=\"$SYMC $NLOK - S&amp;P Global rates Symantec BBB-, places on CreditWatch with negative implications following LifeLock acquisition https://seekingalpha.com/news/3226165-s-and-p-global-rates-symantec-bbb-places-on-creditwatch-negative-implications-following?source=tweet\" data-url=\"https://seekingalpha.com/news/3226165-s-and-p-global-rates-symantec-bbb-places-on-creditwatch-negative-implications-following\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226161\" data-ts=\"1479761064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOP\" target=\"_blank\">GLOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226161-gaslog-partners-started-buy-teekay-lng-partners-hold-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GasLog Partners started at Buy, Teekay LNG Partners at Hold by Stifel</a></h4><ul>     <li>GasLog Partners (<a href=\"https://seekingalpha.com/symbol/GLOP\" title=\"GasLog Partners LP\">GLOP</a> <font color=\"green\">+2%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Starts+GasLog+Partners+LP+%28GLOP%29+at+Buy/12269779.html\" target=\"_blank\">initiated at Buy</a> with a $24 price target at Stifel, which believes the marine MLP is well positioned for growth given a strong backlog  of dropdown candidates at the sponsor levels and the strengthening  fundamentals of the liquefied natural gas market.</li>     <li>The firm expects GLOP distributions to grow  by at least 10%/year for the next several years and thinks units are attractively valued, trading at a 9.7% yield.</li>     <li>Stifel also initiates Teekay LNG Partners (<a href=\"https://seekingalpha.com/symbol/TGP\" title=\"Teekay LNG Partners L.P.\">TGP</a> <font color=\"green\">+3.5%</font>) with a <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Starts+Teekay+LNG+Partners+%28TGP%29+at+Hold/12269780.html\" target=\"_blank\">Hold rating</a> and $14.50 price target, believing that TGP can now refocus on absorbing built-in growth now that it has largely refinanced and recapitalized the business.</li>     <li>But the firm says several loans remain to be refinanced and several vessels are not earning their full contracted rates, thus distribution growth likely will be gradual and back-end loaded for 2018 and 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226161\" data-linked=\"GasLog Partners started at Buy, Teekay LNG Partners at Hold by Stifel\" data-tweet=\"$GLOP $GLOP $TGP - GasLog Partners started at Buy, Teekay LNG Partners at Hold by Stifel https://seekingalpha.com/news/3226161-gaslog-partners-started-buy-teekay-lng-partners-hold-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3226161-gaslog-partners-started-buy-teekay-lng-partners-hold-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226157\" data-ts=\"1479759716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226157-disney-tripped-up-after-report-of-amazon-live-sports-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney tripped up after report of Amazon live sports interest</a></h4><ul>\n<li>Disney (NYSE:<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a>) moved lower after The Wall Street Journal reported that Amazon is in talks with professional sports leagues about live rights for games.</li>\n<li>Sources say the company is considering a premium sports package tied to its Prime program.</li>\n<li>Nothing definitive has been established yet by the Seattle e-commerce giant.</li>\n<li>Shares of Disney were down over 1% initially after the news broke before recovering back.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3226155-amazon-considered-exploring-live-sports-prime-package\" target=\"_blank\">Amazon considered to be exploring live sports Prime package</a> (Nov. 21)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226157\" data-linked=\"Disney tripped up after report of Amazon live sports interest\" data-tweet=\"$DIS - Disney tripped up after report of Amazon live sports interest https://seekingalpha.com/news/3226157-disney-tripped-up-after-report-of-amazon-live-sports-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3226157-disney-tripped-up-after-report-of-amazon-live-sports-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226158\" data-ts=\"1479759496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXL\" target=\"_blank\">SXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226158-energy-transfer-simplification-means-8-declines-for-sxl-etp-eteplus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer simplification means 8% declines for SXL, ETP; ETE +3%</a></h4><ul>     <li>Both Sunoco Logistics Partners (<a href=\"https://seekingalpha.com/symbol/SXL\" title=\"Sunoco Logistics Partners, L.P.\">SXL</a> <font color=\"red\">-7.8%</font>) and Energy Transfer Partners (ETP <font color=\"red\">-7.9%</font>) trade sharply lower on news of the plan for the much smaller <a href=\"https://seekingalpha.com/news/3226045-sunoco-logistics-acquire-energy-transfer-partners\" target=\"_blank\">SXL to purchase ETP</a> that will result in a net implicit reduction in distribution yield for ETP unitholders.</li>     <li>ETP investors will receive 1.5 units of SXL for each unit of ETP they own but their payouts will be reduced since SXL has a much lower dividend yield; CreditSights says the merger amounts to a \u201c<a href=\"http://blogs.barrons.com/incomeinvesting/2016/11/21/energy-transfer-to-merge-2-mlps-called-stealth-distribution-cut/?mod=BOL_hp_blog_ii\" target=\"_blank\">stealth distribution cut</a>\u201d that reduces the ETP cash payout by 29%.</li>     <li>Bernstein Research notes CEO Kelcy Warren chose a path that protects Energy Transfer Equity (ETE <font color=\"green\">+2.8%</font>), the entity in the group of companies in which he holds more than 10% of shares outstanding.</li>     <li>But analysts generally are pleased that the deal - if it is approved by unitholders - will <a href=\"http://www.wsj.com/articles/sunoco-logistics-to-buy-energy-transfer-owners-of-dakota-access-pipeline-1479742796\" target=\"_blank\">simplify ETE's complex structure</a>, which also includes Sunoco LP (<a href=\"https://seekingalpha.com/symbol/SUN\" title=\"Sunoco LP\">SUN</a> <font color=\"red\">-3.6%</font>) and PennTex Midstream Partners (<a href=\"https://seekingalpha.com/symbol/PTXP\" title=\"PennTex Midstream Partners\">PTXP</a> <font color=\"green\">+0.8%</font>); Baird analyst Ethan Bellamy calls the deal \"a major step in untangling... the most complex web of publicly traded partnerships.\"</li>     <li>Seaport Global's Sunil Sibal calculates that the deal will lead to a distribution reduction of ~$1.22 per ETP unit, or $650M, but <a href=\"http://www.forbes.com/sites/clairepoole/2016/11/21/is-there-value-in-sunoco-logistics-merger-with-energy-transfer-partners\" target=\"_blank\">could turn out well in the long run</a>, lowering the cost of capital through the Energy Transfer complex and positioning it for acquisitions as the industry continues to consolidate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226158\" data-linked=\"Energy Transfer simplification means 8% declines for SXL, ETP; ETE +3%\" data-tweet=\"$SXL $SXL $ET - Energy Transfer simplification means 8% declines for SXL, ETP; ETE +3% https://seekingalpha.com/news/3226158-energy-transfer-simplification-means-8-declines-for-sxl-etp-eteplus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3226158-energy-transfer-simplification-means-8-declines-for-sxl-etp-eteplus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226156\" data-ts=\"1479758434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226156-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/LOCK' title='LifeLock, Inc.'>LOCK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MDSY' title='ModSys International Ltd.'>OTC:MDSY</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AMCC' title='Applied Micro Circuits Corporation'>AMCC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> MSDI <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226156\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$MVIS $LOCK $MDSY - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3226156-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3226156-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226153\" data-ts=\"1479758380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226153-oil-perky-on-hopes-for-output-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil perky on hopes for output deal</a></h4><ul>\n<li>The latest chatter on some sort of agreement comes from Libyan OPEC Governor Mohamed Oun, who says the cartel is discussing an output range of 32.5M-33M barrels per day (vs. current levels just north of 35M).</li>\n<li>OPEC meets to maybe hammer out a formal deal later this month.</li>\n<li>Source: Bloomberg</li>\n<li>WTI crude today is <font color=\"green\">higher by 3.9%</font> to $47.48 per barrel - now up about $4 per barrel over the past few sessions.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILK\" title=\"ProShares K-1 Free Crude Oil Strategy ETF\">OILK</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226153\" data-linked=\"Oil perky on hopes for output deal\" data-tweet=\"$USO $OIL $UWTI - Oil perky on hopes for output deal https://seekingalpha.com/news/3226153-oil-perky-on-hopes-for-output-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3226153-oil-perky-on-hopes-for-output-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226150\" data-ts=\"1479757880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZO\" target=\"_blank\">AZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226150-auto-parts-stores-rally-after-credit-suisse-says-trends-line-up-favorably\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto parts stores rally after Credit Suisse says trends line up favorably</a></h4><ul> <li>AutoZone (<a href=\"https://seekingalpha.com/symbol/AZO\" title=\"AutoZone, Inc\">AZO</a> <font color=\"green\">+2.9%</font>) is rallying after Credit Suisse calls it the \"top way to play\" the improved outlook for the auto parts sector.</li> <li>CS thinks weather will reaccelerate growth over the next few months on top of some other macro headwinds for the sector.</li> <li>Advance Auto Parts (<a href=\"https://seekingalpha.com/symbol/AAP\" title=\"Advance Auto Parts, Inc.\">AAP</a> <font color=\"green\">+2.9%</font>), O'Reilly Automotive (<a href=\"https://seekingalpha.com/symbol/ORLY\" title=\"O'Reilly Automotive, Inc.\">ORLY</a> <font color=\"green\">+1.7%</font>) and Genuine Parts (<a href=\"https://seekingalpha.com/symbol/GPC\" title=\"Genuine Parts Company\">GPC</a> <font color=\"green\">+1.8%</font>) are also higher on the day.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226150\" data-linked=\"Auto parts stores rally after Credit Suisse says trends line up favorably\" data-tweet=\"$AZO $AZO $AAP - Auto parts stores rally after Credit Suisse says trends line up favorably https://seekingalpha.com/news/3226150-auto-parts-stores-rally-after-credit-suisse-says-trends-line-up-favorably?source=tweet\" data-url=\"https://seekingalpha.com/news/3226150-auto-parts-stores-rally-after-credit-suisse-says-trends-line-up-favorably\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226149\" data-ts=\"1479757629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226149-antero-resources-rice-energy-rise-to-buy-from-hold-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources, Rice Energy rise to Buy from Hold at Deutsche Bank</a></h4><ul>     <li>Antero Resources (<a href=\"https://seekingalpha.com/symbol/AR\" title=\"Antero Resources Corporation\">AR</a> <font color=\"green\">+1.7%</font>) and Rice Energy (<a href=\"https://seekingalpha.com/symbol/RICE\" title=\"Rice Energy Inc\">RICE</a> <font color=\"green\">+5.2%</font>) are both <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/11/8724091/winter-is-coming-2-energy-stocks-deutsche-is-warming-to-\" target=\"_blank\">upgraded to Buy</a> from Hold at Deutsche Bank, which sees the companies as having the potential to generate \u201cconsistent growth across two high quality asset bases with good entry points for investors.\"</li>     <li>Deutsche Bank believes AR is one of the best positioned producers, given its growth, hedge book and asset base, and says the company largely insulated in 2017 with gas hedges in place.</li>     <li>The firm likes Rice's integrated business model and management\u2019s disciplined approach to consolidation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226149\" data-linked=\"Antero Resources, Rice Energy rise to Buy from Hold at Deutsche Bank\" data-tweet=\"$AR $AR $RICE - Antero Resources, Rice Energy rise to Buy from Hold at Deutsche Bank https://seekingalpha.com/news/3226149-antero-resources-rice-energy-rise-to-buy-from-hold-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3226149-antero-resources-rice-energy-rise-to-buy-from-hold-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226147\" data-ts=\"1479756309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226147-arista-networksplus-7_5-eos-ruled-outside-scope-of-itc-limited-exclusion-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista Networks +7.5%, EOS ruled outside scope of ITC limited exclusion order</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/filing/3299049\" target=\"_blank\">By the U.S. Customs and Border Protection</a>, effectively lifting restrictions on import of associated products to the United States. The ITC, though, is noted to remain unbound by the CBP decision and that the ruling could be modified or revoked should errors or other conflict with future findings be determined.</li>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2016/11/21/arista-surges-6-customs-ruling-can-save-their-profit-margin-says-street/\" target=\"_blank\">Subsequent analyst reaction</a> \u2013 Arista Networks (NYSE:<a href=\"https://seekingalpha.com/symbol/ANET\" title=\"Arista Networks, Inc.\">ANET</a>) target raised from $84 to $95 (current price $94.54) at RBC Capital Markets (Sector Perform) and from $93 to $110 at BMO Capital Markets (Outperform).</li>\n<li>Previously (August 23) \u2013 <a href=\"https://seekingalpha.com/news/3204952-cisco-trade-representative-upholds-import-ban-arista-networks\" target=\"_blank\">Cisco: Trade Representative upholds import ban on Arista Networks</a>\n</li>\n<li>Previously (June 23) \u2013 <a href=\"https://seekingalpha.com/news/3190361-itc-upholds-cisco-victory-arista-patent-case-anet-minus-3_8-percent\" target=\"_blank\">ITC upholds Cisco victory in Arista patent case; ANET -3.8%</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226147\" data-linked=\"Arista Networks +7.5%, EOS ruled outside scope of ITC limited exclusion order\" data-tweet=\"$ANET $CSCO - Arista Networks +7.5%, EOS ruled outside scope of ITC limited exclusion order https://seekingalpha.com/news/3226147-arista-networksplus-7_5-eos-ruled-outside-scope-of-itc-limited-exclusion-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3226147-arista-networksplus-7_5-eos-ruled-outside-scope-of-itc-limited-exclusion-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226146\" data-ts=\"1479756284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226146-beverage-stocks-setting-pace-in-consumer-goods-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beverage stocks setting the pace in consumer goods sector</a></h4><ul> <li>Monster Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a>) is <font color='green'>up 4.51%</font> on a huge volume move.</li> <li>Other beverage stocks with a head of steam include National Beverage Corporation (<a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='green'>+4.2%</font>), Boston Beer (<a href='https://seekingalpha.com/symbol/SAM' title='Boston Beer Co.'>SAM</a> <font color='green'>+2.2%</font>), Molson Coors (<a href='https://seekingalpha.com/symbol/TAP' title='Molson Coors Brewing Company'>TAP</a> <font color='green'>+1.9%</font>), Dr Pepper Snapple (<a href='https://seekingalpha.com/symbol/DPS-OLD' title='Dr Pepper Snapple Group, Inc.'>DPS-OLD</a> <font color='green'>+1.8%</font>) and Jones Soda (<a href='https://seekingalpha.com/symbol/JSDA' title='Jones Soda Co.'>OTC:JSDA</a> <font color='green'>+2.8%</font>). Leading Brands (<a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+12.1%</font>) moved higher after a bullish <a href=\"https://seekingalpha.com/article/4025176-leading-brands-poised-acquired\" target=\"_blank\">Seeking Alpha article</a> went live.</li> <li>It's not clear why the names are attracting so much attention today from investors (M&amp;A intrigue?), but as a group beverage stocks are the top performer in the consumer goods sector.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226146\" data-linked=\"Beverage stocks setting the pace in consumer goods sector\" data-tweet=\"$MNST $MNST $FIZZ - Beverage stocks setting the pace in consumer goods sector https://seekingalpha.com/news/3226146-beverage-stocks-setting-pace-in-consumer-goods-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3226146-beverage-stocks-setting-pace-in-consumer-goods-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226144\" data-ts=\"1479754904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226144-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ORIG' title='Ocean Rig UDW Inc.'>ORIG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+13%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KGJI' title='KINGOLD JEWELRY'>KGJI</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-11%</font>. URRE <font color='red'>-9%</font>. ETP <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226144\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$CHNR $NADL $LLEX - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3226144-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3226144-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226138\" data-ts=\"1479753356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARA\" target=\"_blank\">ARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226138-goldman-negative-on-american-renal-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman negative on American Renal; shares down 9%</a></h4><ul>\n<li>Thinly traded American Renal Associates (<a href=\"https://seekingalpha.com/symbol/ARA\" title=\"American Renal Associates Holdings\">ARA</a> <font color=\"red\">-8.6%</font>) slumps on slightly higher volume pressured by Goldman Sachs' downgrade to Sell from Neutral. Analyst Matthew Borsch cites the company's decision to temporarily suspend certain assistance for charitable premium support as a \"key risk\" to its pricing and earnings growth. Despite the cloudy outlook, he raised the price target to $22 (0%) upside from $20.</li>\n<li>Competitor DaVita (<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a> <font color=\"green\">+2%</font>) suspended its premium support activities several weeks ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226138\" data-linked=\"Goldman negative on American Renal; shares down 9%\" data-tweet=\"$ARA $ARA $DVA - Goldman negative on American Renal; shares down 9% https://seekingalpha.com/news/3226138-goldman-negative-on-american-renal-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3226138-goldman-negative-on-american-renal-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226139\" data-ts=\"1479753103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNR\" target=\"_blank\">RNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226139-renaissancere-slips-deutsche-takes-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RenaissanceRe slips as Deutsche takes profits</a></h4><ul>\n<li>The stock is \"no longer attractive as a new money investment,\" says analyst Joshua Shanker following <font color=\"green\">a 16% rise</font> YTD, with most of that in the last couple of months.</li>\n<li>Even with the strong move of late, large-cap P&amp;C names have underperformed other financials, and this could continue as rising interest rates may mean more difficult pricing and mark-to-market fixed-income losses.</li>\n<li>Source: Bloomberg</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/RNR\" title=\"RenaissanceRe Holdings Ltd.\">RNR</a> <font color=\"red\">-0.75%</font> on the session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226139\" data-linked=\"RenaissanceRe slips as Deutsche takes profits\" data-tweet=\"$RNR - RenaissanceRe slips as Deutsche takes profits https://seekingalpha.com/news/3226139-renaissancere-slips-deutsche-takes-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/3226139-renaissancere-slips-deutsche-takes-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226135\" data-ts=\"1479752862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGLE\" target=\"_blank\">AGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226135-aeglea-bios-aeb3103-shows-encouraging-anti-tumor-action-in-preclinical-studies-big-up-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeglea Bio&#39;s AEB3103 shows encouraging anti-tumor action in preclinical studies; big up move wilts</a></h4><ul>\n<li>Thinly traded nano cap Aeglea BioTherapeutics (<a href=\"https://seekingalpha.com/symbol/AGLE\" title=\"Aeglea BioTherapeutics\">AGLE</a> <font color=\"green\">+1.4%</font>) was up almost 80% but failed to hold onto the gain. The action was apparently stoked by positive results from preclinical studies assessing <a href=\"http://aegleabio.com/pipeline/aecase-cysteine-degradation\" target=\"_blank\">AEB3103 </a>in prostate cancer and breast cancer models. The data were published online today in <em>Nature Medicine</em>.</li>\n<li>AEB3103 is an engineered human enzyme that targets the degradation of the amino acid cysteine/cystine. The company says that no native human cysteine/cystine-degrading enzyme has been identified (until now).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226135\" data-linked=\"Aeglea Bio&#39;s AEB3103 shows encouraging anti-tumor action in preclinical studies; big up move wilts\" data-tweet=\"$AGLE - Aeglea Bio&#39;s AEB3103 shows encouraging anti-tumor action in preclinical studies; big up move wilts https://seekingalpha.com/news/3226135-aeglea-bios-aeb3103-shows-encouraging-anti-tumor-action-in-preclinical-studies-big-up-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3226135-aeglea-bios-aeb3103-shows-encouraging-anti-tumor-action-in-preclinical-studies-big-up-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226136\" data-ts=\"1479752748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNBC\" target=\"_blank\">FNBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226136-first-nbc-on-move-on-reported-deal-discussions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First NBC on the move on reported deal discussions</a></h4><ul><li>According to DealReporter, First NBC (<a href=\"https://seekingalpha.com/symbol/FNBC\" title=\"First NBC Bank Holding Company\">OTC:FNBC</a> <font color=\"green\">+15.1%</font>) is in talks with two possible buyers - namely \"prime contenders\" Iberiabank (<a href=\"https://seekingalpha.com/symbol/IBKC\" title=\"IBERIABANK Corporation\">IBKC</a> <font color=\"red\">-1.1%</font>) and Hancock Holding (<a href=\"https://seekingalpha.com/symbol/HBHC\" title=\"Hancock Holding Company\">HBHC</a> <font color=\"red\">-0.4%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3226136\" data-linked=\"First NBC on the move on reported deal discussions\" data-tweet=\"$FNBC $FNBC $IBKC - First NBC on the move on reported deal discussions https://seekingalpha.com/news/3226136-first-nbc-on-move-on-reported-deal-discussions?source=tweet\" data-url=\"https://seekingalpha.com/news/3226136-first-nbc-on-move-on-reported-deal-discussions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226134\" data-ts=\"1479752288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226134-cheap-fixed-income-etfs-get-barrons-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Cheap&#39; fixed-income ETFs get Barron&#39;s boost</a></h4><ul>\n<li>The sharp selloff in fixed-income not only may have gone too far, <a href=\"http://www.barrons.com/articles/bonds-suddenly-look-like-a-bargain-what-to-buy-now-1479537613\" target=\"_blank\">suggests Andrew Bary</a>, noting a 10-year Treasury yield of 2.33% already discounts plenty of things that may happen in the coming months (or may not happen).</li>\n<li>Whether rates are too high or not is up for argument, but what isn't are the discounts to NAV on at least a few closed-end funds.</li>\n<li>Those mentioned: Nuveen AMT-Free Quality Municipal Income (<a href=\"https://seekingalpha.com/symbol/NEA\" title=\"Nuveen AMT-Free Quality Municipal Income Fund\">NEA</a> <font color=\"green\">+1.5%</font>), BlackRock Municipal 2030 Target Term Trust (<a href=\"https://seekingalpha.com/symbol/BTT\" title=\"Blackrock Municipal Target Term Trust\">BTT</a> <font color=\"green\">+0.9%</font>), BlackRock Taxable Municipal Bond Trust (<a href=\"https://seekingalpha.com/symbol/BBN\" title=\"BlackRock Build America Bond Trust\">BBN</a> <font color=\"green\">+1.5%</font>), Nuveen Preferred Income Opportunities (<a href=\"https://seekingalpha.com/symbol/JPC\" title=\"Nuveen Preferred Income Opportunities Fund\">JPC</a> <font color=\"green\">+2.2%</font>).</li>\n<li>Also noted is a mutual fund which has sold off: Vanguard Intermediate-Term Tax-Exempt Fund (MUTF:<a href=\"https://seekingalpha.com/symbol/VWIUX\" title=\"Vanguard Intermediate-Term Tax-Exempt Fund\">VWIUX</a>).</li>\n<li>Another way to play is in preferred stock, with issues from Wells Fargo, Bank of America, and Public Storage all mentioned, or the iShares Preferred Stock ETF (<a href=\"https://seekingalpha.com/symbol/PFF\" title=\"iShares U.S. Preferred Stock ETF\">PFF</a> <font color=\"green\">+0.8%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226134\" data-linked=\"&#39;Cheap&#39; fixed-income ETFs get Barron&#39;s boost\" data-tweet=\"$NEA $BTT $BBN - &#39;Cheap&#39; fixed-income ETFs get Barron&#39;s boost https://seekingalpha.com/news/3226134-cheap-fixed-income-etfs-get-barrons-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3226134-cheap-fixed-income-etfs-get-barrons-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226130\" data-ts=\"1479751907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMP\" target=\"_blank\">CEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226130-cempra-off-8-bulls-dwindle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cempra off 8% as bulls dwindle</a></h4><ul>\n<li>Cempra (<a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"red\">-7.9%</font>) bulls among analysts just <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/11/21/cempra-another-bull-bites-the-dust/?mod=BOL_hp_blog_stw\" target=\"_blank\">lost one of their own</a>. Cowen and Company's Ritu Baral just downgraded the stock to Market Perform citing the lack of clarity with lead product candidate solithromycin.</li>\n<li>Since the close 7-6 Ad Comm vote several weeks ago, there have been a rash of downgrades. According to MarketBeat, there are three Buy ratings on the stock and eight Hold/Underweight ratings. Before the Ad Comm, 10 of 11 analysts rated the stock a Buy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226130\" data-linked=\"Cempra off 8% as bulls dwindle\" data-tweet=\"$CEMP - Cempra off 8% as bulls dwindle https://seekingalpha.com/news/3226130-cempra-off-8-bulls-dwindle?source=tweet\" data-url=\"https://seekingalpha.com/news/3226130-cempra-off-8-bulls-dwindle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226125\" data-ts=\"1479751324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226125-wainwright-likes-kite-pharma-see-45-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wainwright likes Kite Pharma, see 45% upside</a></h4><ul><li>H.C. Wainwright initiates coverage of Kite Pharma (<a href=\"https://seekingalpha.com/symbol/KITE\" title=\"Kite Pharma\">KITE</a> <font color=\"green\">+3.6%</font>) with a Buy rating and $78 (45% upside) price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226125\" data-linked=\"Wainwright likes Kite Pharma, see 45% upside\" data-tweet=\"$KITE - Wainwright likes Kite Pharma, see 45% upside https://seekingalpha.com/news/3226125-wainwright-likes-kite-pharma-see-45-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3226125-wainwright-likes-kite-pharma-see-45-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226118\" data-ts=\"1479751215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226118-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MN' title='Manning & Napier'>MN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LFC' title='China Life Insurance Company Limited'>LFC</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/NRT' title='North European Oil Royalty Trust'>NRT</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226118\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MN $FNBC $BSBR - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3226118-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3226118-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226117\" data-ts=\"1479750610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KGJI\" target=\"_blank\">KGJI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226117-kingold-jewelry-stung-fraud-accusation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kingold Jewelry stung by fraud accusation</a></h4><ul><li>In an Instablog post, <a href=\"https://seekingalpha.com/instablog/38682326-aurelius/4934901-kgji-fraud-school-success-story\" target=\"_blank\">Seeking Alpha contributor Aurelius</a> calls Kingold Jewelry (<a href='https://seekingalpha.com/symbol/KGJI' title='KINGOLD JEWELRY'>KGJI</a> <font color='red'>-16.7%</font>) a \"fraud school\" success story with documents showing the typical reverse takeover mix of fabricated SEC filings, false statements, and related party transactions.</li><li>He notes the company appears to be poised to launch another U.S. capital raise, despite mulling a potential buyback earlier this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226117\" data-linked=\"Kingold Jewelry stung by fraud accusation\" data-tweet=\"$KGJI - Kingold Jewelry stung by fraud accusation https://seekingalpha.com/news/3226117-kingold-jewelry-stung-fraud-accusation?source=tweet\" data-url=\"https://seekingalpha.com/news/3226117-kingold-jewelry-stung-fraud-accusation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226116\" data-ts=\"1479750523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226116-microvisionplus-16-license-agreement-struck-taiwanese-odm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision +16%, license agreement struck with Taiwanese ODM</a></h4><ul>\n<li>To make and sell laser beam scanning engines. MicroVision to receive royalties for each engine sold. The development is related to the company's <a href=\"https://seekingalpha.com/news/3223400-microvision-plus-11-percent-pre-market-collaborating-stmicroelectronics-laser-beam-scanning\" target=\"_blank\">newly formed collaboration with STMicroelectronics</a>, made known earlier this month.</li>\n<li>MicroVision (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a>) shares are presently trading higher by <font color=\"green\">19.40%</font> on a 5-day term, <font color=\"green\">38.35%</font> on the month and <font color=\"green\">4%</font> over the last three.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226116\" data-linked=\"MicroVision +16%, license agreement struck with Taiwanese ODM\" data-tweet=\"$MVIS - MicroVision +16%, license agreement struck with Taiwanese ODM https://seekingalpha.com/news/3226116-microvisionplus-16-license-agreement-struck-taiwanese-odm?source=tweet\" data-url=\"https://seekingalpha.com/news/3226116-microvisionplus-16-license-agreement-struck-taiwanese-odm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226111\" data-ts=\"1479750093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226111-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> RXII <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a> <font color='green'>+28%</font>. MIRN <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/HW' title='Headwaters Incorporated'>HW</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TK' title='Teekay Corporation'>TK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/LOCK' title='LifeLock, Inc.'>LOCK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MDSY' title='ModSys International Ltd.'>OTC:MDSY</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-14%</font>. SGNL <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/KGJI' title='KINGOLD JEWELRY'>KGJI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/RLOG' title='Rand Logistics, Inc.'>RLOG</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226111\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PHIO $CHNR $ALBO - Midday Gainers / Losers https://seekingalpha.com/news/3226111-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3226111-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226108\" data-ts=\"1479749216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSBR\" target=\"_blank\">BSBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226108-large-and-mid-cap-stocks-making-52-week-highs-lows-on-unusual-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Large- and mid-cap stocks making 52-week highs/lows on unusual volume</a></h4><ul><li>52-week highs on 3x or more normal volume:</li><li>Banco Santander Brasil (<a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+5.8%</font>) - now&nbsp;<font color='green'>up 120%</font>&nbsp;YTD</li><li>Energy Transfer Equity (ETE <font color='green'>+3.4%</font>) - Energy Transfer Partners <a href=\"https://seekingalpha.com/news/3226045-sunoco-logistics-acquire-energy-transfer-partners\" target=\"_blank\">being acquired</a></li><li>Arista Networks (<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='green'>+6.1%</font>)</li><li>Hillenbrand (<a href='https://seekingalpha.com/symbol/HI' title='Hillenbrand, Inc.'>HI</a> <font color='green'>+1.3%</font>)</li><li>International Game Technology (<a href='https://seekingalpha.com/symbol/IGT' title='International Game Technology'>IGT</a> <font color='red'>-4.3%</font>) - <a href=\"https://seekingalpha.com/news/3226032-international-game-technology-plus-6-percent-q3-forecasts\" target=\"_blank\">strong results</a>, but now reversing</li><li>Lexmark International (<a href='https://seekingalpha.com/symbol/LXK' title='Lexmark International, Inc.'>LXK</a> <font color='green'>+0.5%</font>)</li><li>52-week lows on just modestly higher than normal volume:</li><li>CubeSmart (<a href='https://seekingalpha.com/symbol/CUBE' title='CubeSmart Common Shares'>CUBE</a> <font color='red'>-0.9%</font>)</li><li>Extra Space Storage (<a href='https://seekingalpha.com/symbol/EXR' title='Extra Space Storage, Inc.'>EXR</a> <font color='red'>-0.9%</font>)</li><li>PLDT (<a href='https://seekingalpha.com/symbol/PHI' title='Philippine Long Distance Telephone Co.'>PHI</a> <font color='red'>-1.9%</font>)</li><li>58.com (<a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a> <font color='red'>-1%</font>)</li><li>Infosys (<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>)</li><li>Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-0.5%</font>)</li><li>Grupo Televisa (<a href='https://seekingalpha.com/symbol/TV' title='Grupo Televisa, S.A.'>TV</a> <font color='red'>-0.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3226108\" data-linked=\"Large- and mid-cap stocks making 52-week highs/lows on unusual volume\" data-tweet=\"$BSBR $BSBR $ET - Large- and mid-cap stocks making 52-week highs/lows on unusual volume https://seekingalpha.com/news/3226108-large-and-mid-cap-stocks-making-52-week-highs-lows-on-unusual-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3226108-large-and-mid-cap-stocks-making-52-week-highs-lows-on-unusual-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226107\" data-ts=\"1479749044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226107-canadian-solarminus-8-q3-solar-shipments-miss-company-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar -8% as Q3 solar shipments miss company guidance</a></h4><ul>     <li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='red'>-8.1%</font>) is sharply lower after reporting in-line <a href=\"https://seekingalpha.com/news/3225951-canadian-solar-eps-line-misses-revenue\" target=\"_blank\">Q3 earnings</a> on a 22% Y/Y drop in revenues to below company guidance, attributed to the dislocation of the global solar market during the quarter and the quarter-end logistic disruption caused by the bankruptcy of Hanjin Shipping.</li>     <li>CSIQ says its Q3 solar module shipments totaled 1,185 MW, of which 1,161 MW was recognized in revenue,  compared to 1,290 MW recognized in revenue in Q2 and company guidance of 1,200-1,300 MW.</li><li>Q3 gross margin was 17.8%, vs. 17.2% in Q2  and company guidance of 14%-16%.</li><li>For Q4, CSIQ expects total solar  module shipments of 1.4-1.5 GW, total revenues of $600M-$750M, and gross margin of 11%-16%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226107\" data-linked=\"Canadian Solar -8% as Q3 solar shipments miss company guidance\" data-tweet=\"$CSIQ - Canadian Solar -8% as Q3 solar shipments miss company guidance https://seekingalpha.com/news/3226107-canadian-solarminus-8-q3-solar-shipments-miss-company-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3226107-canadian-solarminus-8-q3-solar-shipments-miss-company-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226105\" data-ts=\"1479748690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226105-albireo-adds-to-a4250-stoked-up-move-shares-ahead-41\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albireo adds to A4250-stoked up move; shares ahead 41%</a></h4><ul>\n<li>Thinly traded micro cap Albireo Pharma (<a href=\"https://seekingalpha.com/symbol/ALBO\" title=\"Albireo Pharma, Inc.\">ALBO</a> <font color=\"green\">+41.2%</font>) heads north on almost a 7x surge in volume, albeit on turnover of only 190K. Shares have rallied <font color=\"green\">145%</font> since November 15 when the company <a href=\"http://finance.yahoo.com/news/albireo-lead-product-candidate-orphan-130000353.html\" target=\"_blank\">announced </a>that the European Medicines Agency designated lead product candidate, Phase 2-stage A4250, for its PRIME program for the treatment of progressive familial intrahepatic cholestasis (PFIC).</li>\n<li>EMA's PRIME, which provides for the accelerated review of the marketing application, is akin to the FDA's Fast Track.</li>\n<li>A4250 is a selective inhibitor of the <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481438/\" target=\"_blank\">ileal bile acid transporter</a> (IBAT), a therapeutic target for constipation-associated diseases.</li>\n<li>Albireo Pharma is the product of the May merger between Biodel and Albireo Limited.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226105\" data-linked=\"Albireo adds to A4250-stoked up move; shares ahead 41%\" data-tweet=\"$ALBO - Albireo adds to A4250-stoked up move; shares ahead 41% https://seekingalpha.com/news/3226105-albireo-adds-to-a4250-stoked-up-move-shares-ahead-41?source=tweet\" data-url=\"https://seekingalpha.com/news/3226105-albireo-adds-to-a4250-stoked-up-move-shares-ahead-41\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226101\" data-ts=\"1479747685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226101-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CRWS' title='Crown Crafts, Inc.'>CRWS</a> <font color='red'>-8%</font>. LTEA <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226101\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FENX $ZXAIY $KNDI - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3226101-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3226101-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226100\" data-ts=\"1479747489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226100-petrobras-to-get-back-60m-in-corruption-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras to get back $60M in corruption probe</a></h4><ul>     <li>Brazilian prosecutors in the Operation Car Wash corruption probe say Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"green\">+4.3%</font>) will <a href=\"http://www.bbc.com/news/world-latin-america-38034497\" target=\"_blank\">receive another 204M reais</a> ($60.4M) retrieved from politicians and companies who agreed to cooperation in the investigation.</li>     <li>The payment is the result of plea deals struck by prosecutors with politicians, and is in addition to more than 500M reais (~$150M) in compensation PBR already has received.</li>     <li>Separately, PBR says an injunction in a civil lawsuit has forced it to <a href=\"http://www.oedigital.com/pipelines/item/13996-injunction-order-disrupts-karoon-petrobras-deal\" target=\"_blank\">suspend the sale</a> of stakes in the Baúna and Tartaruga Verde oil fields to Australia's Karoon Gas; it says it plans to appeal the decisions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226100\" data-linked=\"Petrobras to get back $60M in corruption probe\" data-tweet=\"$PBR - Petrobras to get back $60M in corruption probe https://seekingalpha.com/news/3226100-petrobras-to-get-back-60m-in-corruption-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3226100-petrobras-to-get-back-60m-in-corruption-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226095\" data-ts=\"1479747013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPIX\" target=\"_blank\">EPIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226095-essa-pharma-nabs-10m-capital-raise-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ESSA Pharma nabs $10M capital raise; shares down 11%</a></h4><ul>\n<li>ESSA Pharma (<a href=\"https://seekingalpha.com/symbol/EPIX\" title=\"ESSA Pharma, Inc.\">EPIX</a> <font color=\"red\">-10.8%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1633932/000127956916004729/ex991.htm\" target=\"_blank\">secures </a>a $10M term loan facility from Silicon Valley Bank (SVB). It can drawn down $8M initially followed by $2M subject to conditions. The interest rate is Wall Street Journal Prime Rate + 3.0%.</li>\n<li>Under the terms of the agreement, ESSA will issue warrants to SVB to purchase stock valued at 4% of the amount borrowed.</li>\n<li>Proceeds will fund working capital.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226095\" data-linked=\"ESSA Pharma nabs $10M capital raise; shares down 11%\" data-tweet=\"$EPIX - ESSA Pharma nabs $10M capital raise; shares down 11% https://seekingalpha.com/news/3226095-essa-pharma-nabs-10m-capital-raise-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3226095-essa-pharma-nabs-10m-capital-raise-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226093\" data-ts=\"1479746765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226093-noble-corp-names-tudor-pickerings-peakes-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. names Tudor Pickering&#39;s Peakes as new CFO</a></h4><ul>     <li>Noble Corp. (<a href=\"https://seekingalpha.com/symbol/NE\" title=\"Noble Corporation plc\">NE</a> <font color=\"green\">+3.5%</font>) names Adam Peakes as its new CFO, effective Jan. 23.</li>\n<li>Peakes has served as managing director and head of OFS investment banking at Tudor Pickering Holt since 2011 after serving in various roles at Goldman Sachs during 2000-11, most recently as managing director of global natural resources in the investment banking division.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3226093\" data-linked=\"Noble Corp. names Tudor Pickering&#39;s Peakes as new CFO\" data-tweet=\"$NE - Noble Corp. names Tudor Pickering&#39;s Peakes as new CFO https://seekingalpha.com/news/3226093-noble-corp-names-tudor-pickerings-peakes-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3226093-noble-corp-names-tudor-pickerings-peakes-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226089\" data-ts=\"1479746302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226089-fresh-52-week-high-for-melco-crown-amid-favorable-trend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresh 52-week high for Melco Crown amid favorable trend</a></h4><ul> <li>Melco Crown (MPEL <font color=\"green\">+3.3%</font>) reached a 52-week high of $19.45 this morning as investors keep betting on the company's potential in China, and perhaps even in Japan in the long term.</li> <li>Earlier, Credit Suisse boosted its rating on MPEL to Outperform from Neutral. There was also a huge sectorwide call from CS when it raised it forecast for 2017 Macau casino revenue to +16% growth vs. +8% prior forecast.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3226021-casino-operators-watch-japan-green-light\" target=\"_blank\">Casino operators watch Japan for green light</a> (Nov. 21)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226089\" data-linked=\"Fresh 52-week high for Melco Crown amid favorable trend\" data-tweet=\"$MLCO - Fresh 52-week high for Melco Crown amid favorable trend https://seekingalpha.com/news/3226089-fresh-52-week-high-for-melco-crown-amid-favorable-trend?source=tweet\" data-url=\"https://seekingalpha.com/news/3226089-fresh-52-week-high-for-melco-crown-amid-favorable-trend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226086\" data-ts=\"1479745852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POST\" target=\"_blank\">POST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226086-post-earnings-analysis-on-post-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings analysis on Post Holdings</a></h4><ul> <li>Wells Fargo backs Post Holdings (<a href=\"https://seekingalpha.com/symbol/POST\" title=\"Post Holdings, Inc.\">POST</a> <font color=\"green\">+3.7%</font>) as a Top Pick after factoring in FQ4 results and guidance.</li> <li>The potential for outperformance with the Michaels business and a bright outlook on cereal underpin the Wells enthusiasm on the food stock.</li> <li>The investment firm moves it valuation range on POST to $102-$103 from $95-$96.</li> <li>Goldman sticks with Buy rating and lifts its price target to $97 on its view that underlying EBITDA generation is strong.</li> <li>Stifel Nicolaus trimmed its PT on Post to $85 from $95.</li>\n<li>There's a more <a href=\"https://seekingalpha.com/article/4024984-post-holdings-continued-caution-warranted\" target=\"_blank\">cautious view </a>on Post from SA contributor The Value Investor.</li> <li>Sources: Bloomberg and <a href=\"https://www.marketbeat.com/stocks/NYSE/POST/\" target=\"_blank\">MarketBeat.com</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226086\" data-linked=\"Post-earnings analysis on Post Holdings\" data-tweet=\"$POST - Post-earnings analysis on Post Holdings https://seekingalpha.com/news/3226086-post-earnings-analysis-on-post-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3226086-post-earnings-analysis-on-post-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226084\" data-ts=\"1479745584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226084-mast-therapeutics-mulling-reverse-merger-shares-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics mulling reverse merger; shares up 16%</a></h4><ul>\n<li>Mast Therapeutics (MSTX <font color=\"green\">+16.2%</font>) reports that its evaluation of strategic alternatives includes a possible reverse merger with a privately-held firm. It says it has received several written indications of interest from companies with synergistic clinical-stage product candidates.</li>\n<li>It is also exploring ways to monetize ifs vepoloxamer assets, including licensing deals.</li>\n<li>Shares cratered in September after vepoloxamer flunked a late-stage study in sickle cell disease.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226084\" data-linked=\"Mast Therapeutics mulling reverse merger; shares up 16%\" data-tweet=\"$SVRA - Mast Therapeutics mulling reverse merger; shares up 16% https://seekingalpha.com/news/3226084-mast-therapeutics-mulling-reverse-merger-shares-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3226084-mast-therapeutics-mulling-reverse-merger-shares-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226085\" data-ts=\"1479745583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226085-reuters-bp-restricts-ceo-dudley-in-iran-decision-making\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: BP restricts CEO Dudley in Iran decision-making</a></h4><ul>     <li>BP (<a href=\"https://seekingalpha.com/symbol/BP\" title=\"BP p.l.c.\">BP</a> <font color=\"green\">+2.1%</font>) has created a new executive committee to explore business in Iran which will <a href=\"http://www.reuters.com/article/us-bp-iran-idUSKBN13G1PU\" target=\"_blank\">exclude its American CEO Bob Dudley</a> to avoid potential violations of U.S. sanctions still in place, Reuters reports.</li>     <li>The new committee is headed by CFO and British national Brian Gilvary, who will coordinate BP's operations in Iran and any discussions with the country's national oil company, according to the report.</li>     <li>BP has yet to sign any deals with Iran, and a lack of clarity over Iran's terms for new production contracts, difficulties facing the banking system due to continued U.S. sanctions, and companies' severe budget constraints due to lower oil prices have kept most oil majors on the sidelines.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226085\" data-linked=\"Reuters: BP restricts CEO Dudley in Iran decision-making\" data-tweet=\"$BP - Reuters: BP restricts CEO Dudley in Iran decision-making https://seekingalpha.com/news/3226085-reuters-bp-restricts-ceo-dudley-in-iran-decision-making?source=tweet\" data-url=\"https://seekingalpha.com/news/3226085-reuters-bp-restricts-ceo-dudley-in-iran-decision-making\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226080\" data-ts=\"1479744227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226080-atyr-pharma-secures-20m-capital-raise-from-silicon-valley-bank-shares-off-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">aTyr Pharma secures $20M capital raise from Silicon Valley Bank; shares off 9%</a></h4><ul>\n<li>aTyr Pharma (<a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-9.3%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1339970/000156459016029511/life-8k_20161118.htm\" target=\"_blank\">closes </a>a $20M term loan facility with Silicon Valley Bank (SVB). The first tranche of $10M was funded on last Friday. Two additional tranches of $5M each may be drawn down later subject to conditions.</li>\n<li>In connection with the loan, the company issues warrants to SVB to purchase common shares equal to 3% of the loan value.</li>\n<li>A portion ($2.6M) of the $10M tranche was used to repay the balance of a prior loan with SVB.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226080\" data-linked=\"aTyr Pharma secures $20M capital raise from Silicon Valley Bank; shares off 9%\" data-tweet=\"$LIFE - aTyr Pharma secures $20M capital raise from Silicon Valley Bank; shares off 9% https://seekingalpha.com/news/3226080-atyr-pharma-secures-20m-capital-raise-from-silicon-valley-bank-shares-off-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3226080-atyr-pharma-secures-20m-capital-raise-from-silicon-valley-bank-shares-off-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226077\" data-ts=\"1479744045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226077-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> RXII <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+11%</font>. MIRN <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-9%</font>. SGNL <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226077\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PHIO $ALBO $EYEG - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3226077-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3226077-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226073\" data-ts=\"1479743354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOT\" target=\"_blank\">TOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226073-total-socar-sign-deal-to-develop-absheron-discovery-in-azerbaijan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Total, SOCAR sign deal to develop Absheron discovery in Azerbaijan</a></h4><ul>     <li>Total (<a href=\"https://seekingalpha.com/symbol/TOT\" title=\"TOTAL S.A.\">TOT</a> <font color=\"green\">+2.3%</font>) says it signed an agreement to team with Azerbaijan's state oil company SOCAR in <a href=\"http://www.marketwatch.com/story/total-sa-signs-deal-to-run-azerbaijan-gas-field-2016-11-21\" target=\"_blank\">developing the country's Absheron natural gas field</a>.</li>     <li>TOT, which does not disclose the amount the joint venture would invest in the field, expects the first phase of production ultimately will yield as many as 35K boe/day.</li>\n<li>TOT will operate the field and take a 40% stake, SOCAR also will own a  40% stake, and French power utility Engie (<a href=\"https://seekingalpha.com/symbol/ENGIY\" title=\"ENGIE SA ADR\">OTCPK:ENGIY</a>) will hold the  rest.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226073\" data-linked=\"Total, SOCAR sign deal to develop Absheron discovery in Azerbaijan\" data-tweet=\"$TOT $TOT $ENGIY - Total, SOCAR sign deal to develop Absheron discovery in Azerbaijan https://seekingalpha.com/news/3226073-total-socar-sign-deal-to-develop-absheron-discovery-in-azerbaijan?source=tweet\" data-url=\"https://seekingalpha.com/news/3226073-total-socar-sign-deal-to-develop-absheron-discovery-in-azerbaijan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226068\" data-ts=\"1479742567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226068-freeport-again-go-to-copper-play-cowen-says-in-upping-target-to-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport again go-to copper play, Cowen says in upping target to $20</a></h4><ul>     <li>Freeport McMoRan's (<a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"green\">+4.1%</font>) stock price target is raised to $20 from $15 at Cowen, which says the stock has <a href=\"http://www.streetinsider.com/Analyst+Comments/Freeport-McMoRan+%28FCX%29+the+Go-To+Copper+Play+Again%2C+PT+to+%2420+-+Cowen/12270668.html\" target=\"_blank\">regained its status</a> as the go-to copper investment vehicle after impressive actions taken by management to right-size the balance sheet.</li>     <li>FCX shares could re-rate higher as the implied copper price in shares is well below current spot prices, Cowen says in maintaining its Outperform rating.</li>     <li>The firm says FCX maintains significant leverage to improving copper prices, in spite of recent copper asset divestitures, and notes that every $0.10/lb. move in copper prices results in a ~$410M change in 2017 EBITDA.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226068\" data-linked=\"Freeport again go-to copper play, Cowen says in upping target to $20\" data-tweet=\"$FCX - Freeport again go-to copper play, Cowen says in upping target to $20 https://seekingalpha.com/news/3226068-freeport-again-go-to-copper-play-cowen-says-in-upping-target-to-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3226068-freeport-again-go-to-copper-play-cowen-says-in-upping-target-to-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226064\" data-ts=\"1479741884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226064-heard-during-tysons-conference-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heard during Tyson&#39;s conference call</a></h4><ul> <li>Execs with Tyson Foods (<a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a> <font color=\"red\">-16%</font>) said during today's earnings conference call that they expect beef and pork costs to fall in FY17. The company is already seeing a favorable trend with livestock costs falling faster than retail prices.</li> <li>An important point of distinction from Tyson is that the CEO switch announced earlier had \"nothing to do\" with the chicken pricing lawsuit.</li>\n<li>Shares of Tyson are at their lowerst level since February after elevated soy meal costs clipped FQ4 results.</li> <li>Source: Bloomberg and <a href=\"http://ir.tyson.com/investor-relations/default.aspx\" target=\"_blank\">Tyson earnings call webcast</a>\n</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3225974-tyson-announces-ceo-succession\" target=\"_blank\">Tyson announces CEO succession</a> (Nov. 21)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3225984-tyson-foods-lower-earnings-miss\" target=\"_blank\">Tyson Foods lower on earnings miss</a> (Nov. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226064\" data-linked=\"Heard during Tyson&#39;s conference call\" data-tweet=\"$TSN - Heard during Tyson&#39;s conference call https://seekingalpha.com/news/3226064-heard-during-tysons-conference-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3226064-heard-during-tysons-conference-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226063\" data-ts=\"1479741844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIO\" target=\"_blank\">PHIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226063-rxi-pharma-joins-nano-cap-biotech-party-shares-up-66\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RXi Pharma joins nano cap biotech party; shares up 66%</a></h4><ul>\n<li>Thinly traded nano cap RXi Pharmaceuticals (RXII <font color=\"green\">+66.3%</font>) jumps on a whopping 33x surge in volume. Shares are up <font color=\"green\">170%</font> since November 8. No particular news accounts for the move but the action resembles other tiny biotechs that have attracted buying in recent weeks.</li>\n<li>On November 10, the company released Q3 results which showed quick assets of $4.4M and an operating loss of $2.2M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226063\" data-linked=\"RXi Pharma joins nano cap biotech party; shares up 66%\" data-tweet=\"$PHIO - RXi Pharma joins nano cap biotech party; shares up 66% https://seekingalpha.com/news/3226063-rxi-pharma-joins-nano-cap-biotech-party-shares-up-66?source=tweet\" data-url=\"https://seekingalpha.com/news/3226063-rxi-pharma-joins-nano-cap-biotech-party-shares-up-66\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226061\" data-ts=\"1479741163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226061-oragenics-lead-product-candidate-fast-trackd-in-u-s-for-oral-mucositis-shares-up-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics&#39; lead product candidate Fast Track&#39;d in U.S. for oral mucositis; shares up 19%</a></h4><ul>\n<li>Thinly traded nano cap Oragenics (<a href=\"https://seekingalpha.com/symbol/OGEN\" title=\"Oragenics, Inc.\">OGEN</a> <font color=\"green\">+18.6%</font>) heads north on increased volume in response to its <a href=\"http://www.businesswire.com/news/home/20161121005390/en/U.S.-FDA-Grants-Fast-Track-Designation-Development\" target=\"_blank\">announcement </a>that the FDA has designated lead product candidate, Phase 2-stage AG013, for Fast Track review for the treatment of oral mucositis.</li>\n<li>AG013 is an oral rinsing solution designed to deliver the therapeutic molecule Trefoil Factor 1 (TFF1) to the mucosal tissues in the oral cavity. <a href=\"http://en.wikipedia.org/wiki/Trefoil_factor_1\" target=\"_blank\">TFFs </a>are a class of peptides that play a key role in protecting the mucosa.</li>\n<li>\n<a href=\"http://www.oralcancerfoundation.org/complications/mucositis.php\" target=\"_blank\">Oral mucositis</a> is a common adverse effect from cancer therapy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226061\" data-linked=\"Oragenics&#39; lead product candidate Fast Track&#39;d in U.S. for oral mucositis; shares up 19%\" data-tweet=\"$OGEN - Oragenics&#39; lead product candidate Fast Track&#39;d in U.S. for oral mucositis; shares up 19% https://seekingalpha.com/news/3226061-oragenics-lead-product-candidate-fast-trackd-in-u-s-for-oral-mucositis-shares-up-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3226061-oragenics-lead-product-candidate-fast-trackd-in-u-s-for-oral-mucositis-shares-up-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226058\" data-ts=\"1479740605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGRLY\" target=\"_blank\">DGRLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226058-noble-energy-israeli-partners-near-4b-financing-deal-for-leviathan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Energy, Israeli partners near $4B financing deal for Leviathan</a></h4><ul>     <li>The companies owning the rights to Israel&rsquo;s Leviathan natural gas field are <a href=\"http://www.bloomberg.com/news/articles/2016-11-21/israel-gas-partners-close-to-4-billion-financing-for-leviathan\" target=\"_blank\">close to securing $4B financing</a> needed for development, according to CEO&nbsp;Yossi Abu of Delek Drilling (<a href='https://seekingalpha.com/symbol/DGRLY' title='Delek Group Ltd. ADR'>OTCPK:DGRLY</a>, <a href='https://seekingalpha.com/symbol/DKDRF' title='Delek Drilling'>OTC:DKDRF</a>), one of the partners.</li>     <li>With a large export contract already in hand - a $10B deal signed two months ago with Jordan's National Electric Power Co. - obtaining the funds is the next milestone for the gas explorers&nbsp;looking to tap the Israel's largest natural gas field, led by Noble Energy (<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color='green'>+2.9%</font>).</li>     <li>The companies have been in talks with major banks since clearing antitrust issues with Israel&rsquo;s government earlier this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226058\" data-linked=\"Noble Energy, Israeli partners near $4B financing deal for Leviathan\" data-tweet=\"$DGRLY $DGRLY $DKDRF - Noble Energy, Israeli partners near $4B financing deal for Leviathan https://seekingalpha.com/news/3226058-noble-energy-israeli-partners-near-4b-financing-deal-for-leviathan?source=tweet\" data-url=\"https://seekingalpha.com/news/3226058-noble-energy-israeli-partners-near-4b-financing-deal-for-leviathan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226057\" data-ts=\"1479740420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTO\" target=\"_blank\">ZTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226057-analyst-coverage-on-zto-express-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst coverage on ZTO Express launches</a></h4><ul> <li>Analyst coverage on ZTO Express (<a href=\"https://seekingalpha.com/symbol/ZTO\" title=\"ZTO Express\">ZTO</a> <font color=\"green\">+1.7%</font>) is pouring in.</li> <li>Credit Suisse rates share at Outperform and sets a price target of $18.10.</li> <li>China Renaissance lines up ZTO as a Buy with a price target of $21.</li> <li>Goldman Sachs (lead underwriter) initiates coverage on ZTO with a Buy rating and $19 PT. The firm forecasts 17% market share for the shipper by 2018.</li> <li>Morgan Stanley (lead underwriter) starts off ZTO at Overweight with a $20 PT.</li>\n<li>ZTO trades below where its IPO was priced ($19.50).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226057\" data-linked=\"Analyst coverage on ZTO Express launches\" data-tweet=\"$ZTO - Analyst coverage on ZTO Express launches https://seekingalpha.com/news/3226057-analyst-coverage-on-zto-express-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/3226057-analyst-coverage-on-zto-express-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226055\" data-ts=\"1479740189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSGX\" target=\"_blank\">HSGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226055-histogenics-faces-delisting-from-nasdaq-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Histogenics faces delisting from Nasdaq; shares down 5%</a></h4><ul><li>Thinly traded nano cap Histogenics (<a href='https://seekingalpha.com/symbol/HSGX' title='Histogenics Corporation'>HSGX</a> <font color='red'>-4.9%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1372299/000119312516772933/d278059d8k.htm\" target=\"_blank\">receives </a>a deficiency notice from Nasdaq citing its failure to maintain a minimum market value of $50M over 30 consecutive business days. The company has 180 calendar days to address the issue before facing possible delisting.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226055\" data-linked=\"Histogenics faces delisting from Nasdaq; shares down 5%\" data-tweet=\"$HSGX $OCGN - Histogenics faces delisting from Nasdaq; shares down 5% https://seekingalpha.com/news/3226055-histogenics-faces-delisting-from-nasdaq-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3226055-histogenics-faces-delisting-from-nasdaq-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226052\" data-ts=\"1479739859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226052-mellanox-socked-jefferies-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mellanox socked by Jefferies downgrade</a></h4><ul>\n<li>After recent trade-show checks, the team at Jefferies is increasingly concerned Mellanox (<a href=\"https://seekingalpha.com/symbol/MLNX\" title=\"Mellanox Technologies, Ltd.\">MLNX</a> <font color=\"red\">-5.5%</font>) will see significant pressure on its InfiniBank business from Intel's launch of Skylake, which could begin shipping in volume as soon as March 2017 vs. the current Street expectation of mid-late 2018.</li>\n<li>Jefferies' newly-initiated CY18 revenue and EPS estimates for MLNX are 6% and 27% below consensus, respectively.</li>\n<li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226052\" data-linked=\"Mellanox socked by Jefferies downgrade\" data-tweet=\"$MLNX - Mellanox socked by Jefferies downgrade https://seekingalpha.com/news/3226052-mellanox-socked-jefferies-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3226052-mellanox-socked-jefferies-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226046\" data-ts=\"1479739403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226046-j-p-morgan-positive-on-facebook-share-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.P. Morgan positive on Facebook share buyback</a></h4><ul><li>Analyst Doug Anmuth highlights Facebook's&nbsp;<a href=\"https://seekingalpha.com/news/3225884-facebook-authorizes-6b-class-share-repurchase\" target=\"_blank\">$6B repurchase authorization</a> as a positive indicator subsequent <a href=\"https://seekingalpha.com/news/3220234-facebook-minus-8-percent-revenue-growth-cautioned-slow\" target=\"_blank\">company-issued caution</a> on anticipated slowing revenue growth and higher expenses and investment, and amid matters involving&nbsp;<a href=\"https://seekingalpha.com/news/3225045-facebook-discloses-new-miscalculated-metrics-minus-1_5-percent\" target=\"_blank\">ad metrics</a> and <a href=\"https://seekingalpha.com/news/3225919-facebook-plans-fight-fake-news\" target=\"_blank\">\"fake news.\"</a></li><li>Considers <a href=\"https://seekingalpha.com/filing/3298363\" target=\"_blank\">resignation of Chief Accounting Officer</a> independent of metrics miscalculations.</li><li>Retains Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>),&nbsp;<font color='green'>higher by 1.5%</font>&nbsp;early, with a <a href=\"http://blogs.barrons.com/techtraderdaily/2016/11/21/facebooks-6b-buyback-a-good-thing-amidst-bad-real-news/\" target=\"_blank\">$175 target and Overweight rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3226046\" data-linked=\"J.P. Morgan positive on Facebook share buyback\" data-tweet=\"$FB - J.P. Morgan positive on Facebook share buyback https://seekingalpha.com/news/3226046-j-p-morgan-positive-on-facebook-share-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3226046-j-p-morgan-positive-on-facebook-share-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226045\" data-ts=\"1479739369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXL\" target=\"_blank\">SXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226045-sunoco-logistics-to-acquire-energy-transfer-partners\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco Logistics to acquire Energy Transfer Partners</a></h4><ul>     <li>Sunoco Logistics Partners (<a href=\"https://seekingalpha.com/symbol/SXL\" title=\"Sunoco Logistics Partners, L.P.\">SXL</a> <font color=\"red\">-1.6%</font>) agrees to acquire Energy Transfer Partners (ETP <font color=\"red\">-1%</font>) in a unit-for-unit transaction.</li>     <li>ETP unitholders will receive 1.5 common units of SXL for each common unit of ETP they own, which equates to a 10% premium to the volume weighted average pricing of ETP\u2019s common units for the last 30 trading days.</li>     <li>The companies say the combined partnership will offer increased scale and diversification across multiple producing basins and have greater opportunities to more closely integrate SXL's natural gas liquids business with ETP's natural gas gathering, processing and transportation business; the companies also anticipate more than $200M/year in commercial synergies and costs savings by 2019.</li>     <li>Kelcy Warren, Chairman of parent company Energy Transfer Equity (ETE <font color=\"green\">+10%</font>), will be CEO of the combined company; ETE will continue to provide all incentive distribution  right subsidies that are currently in effect for both  partnerships.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226045\" data-linked=\"Sunoco Logistics to acquire Energy Transfer Partners\" data-tweet=\"$SXL $SXL $ET - Sunoco Logistics to acquire Energy Transfer Partners https://seekingalpha.com/news/3226045-sunoco-logistics-to-acquire-energy-transfer-partners?source=tweet\" data-url=\"https://seekingalpha.com/news/3226045-sunoco-logistics-to-acquire-energy-transfer-partners\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>272&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226044\" data-ts=\"1479739358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOSL\" target=\"_blank\">FOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226044-fossil-rallies-after-piper-jaffray-weighs-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fossil rallies after Piper Jaffray weighs in</a></h4><ul> <li>Fossil (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FOSL\" title=\"Fossil, Inc.\">FOSL</a>) races higher in early action after shaking off a bearish rating from Piper Jaffray.</li> <li>PJ <a href=\"https://twitter.com/ConsumerFeed/status/800678811977203712\" target=\"_blank\">moves</a> to Neutral from Underweight and assigns a 12-month price target of $32.</li> <li>Shares of Fossil are <font color=\"green\">up 4.08%</font> to $35.73 vs. a 52-week trading range of $23.10 to $51.93.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226044\" data-linked=\"Fossil rallies after Piper Jaffray weighs in\" data-tweet=\"$FOSL - Fossil rallies after Piper Jaffray weighs in https://seekingalpha.com/news/3226044-fossil-rallies-after-piper-jaffray-weighs-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3226044-fossil-rallies-after-piper-jaffray-weighs-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226032\" data-ts=\"1479738271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGT\" target=\"_blank\">IGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226032-international-game-technologyplus-6-q3-over-forecasts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Game Technology +6%; Q3 over forecasts</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3225957-international-game-technology-beats-0_01-beats-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $1.27B (+5.8% Y/Y, <font color=\"green\">$20M above estimates</font>), EPS $0.45 (<font color=\"green\">$0.01 above estimates</font>), adjusted operating income $286M (+9% Y/Y), adjusted EBITDA $430M (+4% Y/Y), adjusted net income $90M (+6% Y/Y)</li>\n<li>\n<strong>Dividend</strong> \u2013 $0.20 payable December 19 to shareholders on record December 5</li>\n<li>\n<strong>FY 2016 projections</strong> \u2013 adjusted EBITDA $1.740B-$1.790B, capital expenditures excluding upfront Lotto concession payments $550M or less, net debt $7.7B-$7.9B</li>\n<li>International Game Technology (NYSE:<a href=\"https://seekingalpha.com/symbol/IGT\" title=\"International Game Technology\">IGT</a>) CEO Marco Sala: \"Strong lottery performance across the world, a larger global installed base, and increased sales of gaming machines drove another quarter of solid revenue and profit expansion. IGT's leadership positions in lottery and gaming machines were evident at the recent gaming and lottery trade shows. The engaging player experiences and technology solutions IGT creates are the cornerstones of our growth strategy, and we are encouraged by customer enthusiasm for our innovative new products.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/IGT/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"https://seekingalpha.com/article/4025114-international-game-technology-2016-q3-results-earnings-call-slides\" target=\"_blank\">Presentation slides</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/vc7r3wgw\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226032\" data-linked=\"International Game Technology +6%; Q3 over forecasts\" data-tweet=\"$IGT - International Game Technology +6%; Q3 over forecasts https://seekingalpha.com/news/3226032-international-game-technologyplus-6-q3-over-forecasts?source=tweet\" data-url=\"https://seekingalpha.com/news/3226032-international-game-technologyplus-6-q3-over-forecasts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226031\" data-ts=\"1479738131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226031-abbvie-backs-out-of-development-of-halozymes-enhanze-and-tnf-halo-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie backs out of development of Halozyme&#39;s ENHANZE and TNF; HALO down 10% premarket</a></h4><ul>\n<li>Halozyme Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a>) eases <font color=\"red\">10%</font> premarket on light volume in response to its <a href=\"http://www.prnewswire.com/news-releases/halozyme-provides-update-on-abbvie-collaboration-300366211.html\" target=\"_blank\">announcement </a>that collaboration partner AbbVie (NYSE:<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a>) has terminated a development program involving Halozyme's ENHANZE platform and the tumor necrosis factor alpha (TNF-alpha). It decided to nix development after a failed Phase 1 study.</li>\n<li>Other work will continue under the companies' 2015 Global Collaboration and Licensing Agreement. TNF-alpha was the first nominated target of nine included in the agreement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226031\" data-linked=\"AbbVie backs out of development of Halozyme&#39;s ENHANZE and TNF; HALO down 10% premarket\" data-tweet=\"$HALO $HALO $ABBV - AbbVie backs out of development of Halozyme&#39;s ENHANZE and TNF; HALO down 10% premarket https://seekingalpha.com/news/3226031-abbvie-backs-out-of-development-of-halozymes-enhanze-and-tnf-halo-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3226031-abbvie-backs-out-of-development-of-halozymes-enhanze-and-tnf-halo-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226027\" data-ts=\"1479737746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226027-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/HW\" title=\"Headwaters Incorporated\">HW</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/DRYS\" title=\"DryShips Inc.\">DRYS</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/LOCK\" title=\"LifeLock, Inc.\">LOCK</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/TNDM\" title=\"Tandem Diabetes Care, Inc.\">TNDM</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/BTE\" title=\"Baytex Energy Corp.\">BTE</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/AMCC\" title=\"Applied Micro Circuits Corporation\">AMCC</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/TRCH\" title=\"Torchlight Energy Resources, Inc.\">TRCH</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/ESEA\" title=\"Euroseas Ltd.\">ESEA</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/DCIX\" title=\"Diana Containerships Inc.\">DCIX</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a> <font color=\"green\">+8%</font>. PBR-A <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/RLOG\" title=\"Rand Logistics, Inc.\">RLOG</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CMCM\" title=\"Cheetah Mobile Inc.\">CMCM</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/GSL\" title=\"Global Ship Lease, Inc\">GSL</a> <font color=\"green\">+5%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/PPC\" title=\"Pilgrim's Pride Corporation\">PPC</a> <font color=\"red\">-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226027\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$HW $DRYS $LOCK - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3226027-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3226027-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226026\" data-ts=\"1479737675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226026-kites-kte-c19-shows-positive-treatment-effect-across-refractory-blood-cancer-subgroups-in-mid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite&#39;s KTE-C19 shows positive treatment effect across refractory blood cancer subgroups in mid-stage study; shares up 1% premarket</a></h4><ul>\n<li>Results from the Zuma-1 study showed Kite Pharma's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KITE\" title=\"Kite Pharma\">KITE</a>) lead product candidate KTE-C19 produced a 76% response rate in patients with certain types of blood cancer who failed to respond to chemotherapy and 80% in those who relapsed after stem cell transplantation. The data will be presented at the American Society of Hematology Annual Meeting in San Diego, CA, December 3-6.</li>\n<li>Progression-free survival was 92% at month 1 and 56% at month 3.</li>\n<li>The company plans to start its rolling NDA submission to the FDA by year end and complete the process in Q1.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210873-kite-pharmas-lead-product-candidate-shows-impressive-efficacy-phase-1-2-study-shares-14\" target=\"_blank\">Kite Pharma's lead product candidate shows impressive efficacy in Phase 1/2 study; shares up 14% after hours</a> (Sept. 26)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226026\" data-linked=\"Kite&#39;s KTE-C19 shows positive treatment effect across refractory blood cancer subgroups in mid-stage study; shares up 1% premarket\" data-tweet=\"$KITE - Kite&#39;s KTE-C19 shows positive treatment effect across refractory blood cancer subgroups in mid-stage study; shares up 1% premarket https://seekingalpha.com/news/3226026-kites-kte-c19-shows-positive-treatment-effect-across-refractory-blood-cancer-subgroups-in-mid?source=tweet\" data-url=\"https://seekingalpha.com/news/3226026-kites-kte-c19-shows-positive-treatment-effect-across-refractory-blood-cancer-subgroups-in-mid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226024\" data-ts=\"1479737513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226024-constellations-brands-announces-new-1b-buyback-allowance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellations Brands announces new $1B buyback allowance</a></h4><ul> <li>Constellation Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a>) <a href=\"http://www.cbrands.com/company-news\" target=\"_blank\">approves</a> a new buyback program of $1B worth of stock.</li> <li>The new buyback allowance is on top of a current $1B share repurchase program.</li> <li>\"We are pleased with our new Investment Grade status, which has been driven by our ability to continue to generate strong earnings and operating cash flow,\" notes Constellation CFO David Klein.</li>\n<li>\"This provides us with the flexibility to be opportunistic with future share repurchases while remaining committed to our 3.5x targeted leverage ratio,\"  he adds.</li> <li>STZ <font color=\"green\">+1.12%</font> premarket to $156.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226024\" data-linked=\"Constellations Brands announces new $1B buyback allowance\" data-tweet=\"$STZ - Constellations Brands announces new $1B buyback allowance https://seekingalpha.com/news/3226024-constellations-brands-announces-new-1b-buyback-allowance?source=tweet\" data-url=\"https://seekingalpha.com/news/3226024-constellations-brands-announces-new-1b-buyback-allowance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226023\" data-ts=\"1479737370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPC\" target=\"_blank\">MPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226023-marathon-petroleum-gets-elliott-letter-urging-full-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Petroleum gets Elliott letter urging &quot;full strategic review&quot;</a></h4><ul>     <li>Marathon Petroleum (NYSE:<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a>) <font color=\"green\">+4.3%</font> premarket on news that Elliott Management sent a letter to the company's board, saying MPC shares are \"severely undervalued\" and making recommendations it says would unlock $14B-$19B for shareholders.</li>     <li>Elliott, which owns ~4% of MPC shares, outlines recommendations it says could result in an uplift of 60%-80% or more in the company's stock by immediately dropping down all MLP-qualifying assets to <a href=\"https://seekingalpha.com/symbol/MPLX\" title=\"MPLX LP\">MPLX</a> and conducting a full strategic review of the company.</li>     <li>The hedge fund also says MPC should consider spinning off its chain of gasoline and convenience stores or break into three businesses, focused on retailing, refining and midstream operations that hold pipeline and storage assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226023\" data-linked=\"Marathon Petroleum gets Elliott letter urging &quot;full strategic review&quot;\" data-tweet=\"$MPC $MPC $MPLX - Marathon Petroleum gets Elliott letter urging &quot;full strategic review&quot; https://seekingalpha.com/news/3226023-marathon-petroleum-gets-elliott-letter-urging-full-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3226023-marathon-petroleum-gets-elliott-letter-urging-full-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226020\" data-ts=\"1479736969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226020-dryships-comes-to-terms-one-lenderplus-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips comes to terms with one lender; +15%</a></h4><ul>\n<li>Under the agreement, the lending bank will write off about 50% of the outstanding principal and interest due, DryShips (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DRYS\" title=\"DryShips Inc.\">DRYS</a>) has repaid about $8.2M of principal and will have to pay another $2M over the next nine months.</li>\n<li>Shares <font color=\"green\">+15% </font>premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226020\" data-linked=\"DryShips comes to terms with one lender; +15%\" data-tweet=\"$DRYS - DryShips comes to terms with one lender; +15% https://seekingalpha.com/news/3226020-dryships-comes-to-terms-one-lenderplus-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3226020-dryships-comes-to-terms-one-lenderplus-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226010\" data-ts=\"1479736133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226010-tandem-trying-to-claw-back-from-recent-plunge-shares-up-19-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem trying to claw back from recent plunge; shares up 19% premarket</a></h4><ul>\n<li>Short sellers are or should be covering their positions in Tandem Diabetes Care (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TNDM\" title=\"Tandem Diabetes Care, Inc.\">TNDM</a>). Shares are up <font color=\"green\">19%</font> premarket on increased volume. The stock has bounced almost 53% since bottoming at $1.70 on November 9.</li>\n<li>Shares plunged earlier this month after a revenue miss and softer guidance.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226010\" data-linked=\"Tandem trying to claw back from recent plunge; shares up 19% premarket\" data-tweet=\"$TNDM - Tandem trying to claw back from recent plunge; shares up 19% premarket https://seekingalpha.com/news/3226010-tandem-trying-to-claw-back-from-recent-plunge-shares-up-19-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3226010-tandem-trying-to-claw-back-from-recent-plunge-shares-up-19-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226009\" data-ts=\"1479735971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXO\" target=\"_blank\">CXO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226009-concho-buys-new-mexico-acreage-for-430m-raises-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concho buys New Mexico acreage for ~$430M, raises production guidance</a></h4><ul>     <li>Concho Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/CXO\" title=\"Concho Resources Inc.\">CXO</a>) <font color=\"green\">+2.6%</font> premarket after agreeing to acquire ~16.4K net acres in the northern  Delaware Basin in New Mexico for ~$430M in cash and stock, and raising its FY 2017  production guidance.</li>     <li>CXO says it will issue 2.18M shares and pay $150M in cash, funded with cash on hand and borrowing from its credit facility as well as potential asset sales.</li>     <li>The deal includes ~2.5K boe/day (69% oil) of current production, and expands its position in the Red Hills area by more than 25% to ~47K net acres.</li>     <li>As a result of the acquisition, CXO says it plans to increase its operated  rig count to an average of eight rigs in the northern Delaware Basin  during 2017, and now expects to grow oil production volumes by more than  20% Y/Y in 2017 and total production by 18%-21%, up from prior guidance of 17%-20%.</li>     <li>CXO also maintains its 2017 capex guidance of $1.4B-$1.6B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3226009\" data-linked=\"Concho buys New Mexico acreage for ~$430M, raises production guidance\" data-tweet=\"$CXO - Concho buys New Mexico acreage for ~$430M, raises production guidance https://seekingalpha.com/news/3226009-concho-buys-new-mexico-acreage-for-430m-raises-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3226009-concho-buys-new-mexico-acreage-for-430m-raises-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226007\" data-ts=\"1479735599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226007-omeros-completes-study-of-omidria-in-children-regulatory-application-to-follow-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros completes study of OMIDRIA in children; regulatory application to follow; shares up 1% premarket</a></h4><ul>\n<li>Per the FDA's post-marketing requirement for <a href=\"http://www.omidria.com/about-omidria/how-it-works/\" target=\"_blank\">OMIDRIA </a>(phenylephrine and ketorolac injection) Omeros (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OMER\" title=\"Omeros Corporation\">OMER</a>) announces the completion of a clinical study assessing the safety of the cataract surgery medicine in children. The trial enrolled ~70 pediatric patients (newborn to age three) undergoing cataract surgery, a rare condition in children.</li>\n<li>OMIDRIA was shown to be safe and well-tolerated with the incidence of adverse events consistent with those observed in pediatric cataract surgery.</li>\n<li>The company will submit a supplemental NDA (sNDA) promptly. The agency has agreed that the results can be extrapolated to patients through 18 years of age.</li>\n<li>The completed study fulfills Omeros' post-marketing commitment and extends OMIDRIA's marketing exclusivity for an additional six months. The FDA approved it in June 2014 to maintain pupil diameter in adults undergoing cataract surgery.</li>\n<li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226007\" data-linked=\"Omeros completes study of OMIDRIA in children; regulatory application to follow; shares up 1% premarket\" data-tweet=\"$OMER - Omeros completes study of OMIDRIA in children; regulatory application to follow; shares up 1% premarket https://seekingalpha.com/news/3226007-omeros-completes-study-of-omidria-in-children-regulatory-application-to-follow-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3226007-omeros-completes-study-of-omidria-in-children-regulatory-application-to-follow-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3225984\" data-ts=\"1479733127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3225984-tyson-foods-lower-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods lower on earnings miss</a></h4><ul>     <li>Tyson Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a>) reports total sales volume fell 8.2% in FQ4.</li>     <li>Segment Sales: Chicken: $2.81B (-7%); Beef: $3.48B (-21.2%); Pork: $1.24B (-5.8%); Prepared Foods: $1.84B (-8.5%); Other: $96M (-11.1%).</li>     <li>Segment Volume change: Chicken: -10.1%; Beef: -7.4%; Pork: -6.8%; Prepared Foods: -4.8%; Other: -11.8%.</li>     <li>Segment Average Price change: Chicken: +3.5%; Beef: -14.9%; Pork: +1%; Prepared Foods: -3.9%; Other: +1.6%.</li>     <li>Gross margin rate rose 250 bps to 11.9%.</li>     <li>SG&amp;A expense rate up 130 bps to 5.5%.</li>     <li>Adjusted operating margin rate grew 60 bps to 6.4%.</li>     <li>The company expects overall domestic protein production to increase ~2% to 3% (Y/Y) in FY2017.</li>     <li>\n<b>FY2017 Guidance</b>: Sales: flat Y/Y; Chicken operating margin: ~ upper end of normalized range of 9% to 11%; Beef: above normalized range of 1.5% - 3%; Pork operating margin: at least 10%; Prepared Foods operating margin: flat Y/Y; Other operating loss: ~$70M; Adjusted EPS: $4.70 - $4.85; Capital expenditure: ~1B; Net interest expense: ~$225M; Liquidity: in range of $1B.</li>     <li>TSN <font color=\"red\">-8.55%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3225984\" data-linked=\"Tyson Foods lower on earnings miss\" data-tweet=\"$TSN - Tyson Foods lower on earnings miss https://seekingalpha.com/news/3225984-tyson-foods-lower-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3225984-tyson-foods-lower-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3225975\" data-ts=\"1479731988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBR\" target=\"_blank\">KBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3225975-infrastructure-play-catches-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infrastructure play catches upgrade</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/symbol/KBR\" title=\"KBR, Inc.\">KBR</a> is <a href=\"http://thefly.com/permalinks/entry.php/id2466289/KBR-KBR-rating-change-at-MKM-Partners\" target=\"_blank\">boosted to Buy</a> from Neutral at MKM Partners, which says likes the new business mix that emphasizes government services and tech.</li>\n<li>The price target of $21 suggests nearly 30% upside from Friday's close of $16.25.</li>\n<li>Shares <font color=\"green\">+2.15%</font> to $16.60 in thin premarket action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3225975\" data-linked=\"Infrastructure play catches upgrade\" data-tweet=\"$KBR - Infrastructure play catches upgrade https://seekingalpha.com/news/3225975-infrastructure-play-catches-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3225975-infrastructure-play-catches-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3225970\" data-ts=\"1479731538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3225970-acorda-nixes-development-of-dalfampridine-for-pswd-after-failed-late-stage-study-shares-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda nixes development of dalfampridine for PSWD after failed late-stage study; shares down 13% premarket</a></h4><ul>\n<li>Acorda Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACOR\" title=\"Acorda Therapeutics, Inc.\">ACOR</a>) slumps <font color=\"red\">13% </font>premarket, albeit on only 450 shares, in response to its <a href=\"http://www.businesswire.com/news/home/20161121005261/en/Acorda-Discontinue-Development-Dalfampridine-Treatment-Post-Stroke-Walking\" target=\"_blank\">announcement </a>that it will discontinue development of dalfampridine to improve post-stroke walking difficulties (PSWD) after a Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02422940?term=dalfampridine&amp;phase=2&amp;rank=3\" target=\"_blank\">MILESTONE</a>, failed to demonstrate a statistically valid treatment effect over placebo.</li>\n<li>Dalfampridine, marketed as <a href=\"https://ampyra.com/\" target=\"_blank\">Ampyra</a>, is currently approved to improve waling in patients with multiple sclerosis.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3225970\" data-linked=\"Acorda nixes development of dalfampridine for PSWD after failed late-stage study; shares down 13% premarket\" data-tweet=\"$ACOR - Acorda nixes development of dalfampridine for PSWD after failed late-stage study; shares down 13% premarket https://seekingalpha.com/news/3225970-acorda-nixes-development-of-dalfampridine-for-pswd-after-failed-late-stage-study-shares-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3225970-acorda-nixes-development-of-dalfampridine-for-pswd-after-failed-late-stage-study-shares-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3225967\" data-ts=\"1479730919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTSI\" target=\"_blank\">MTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3225967-macom-technology-buying-applied-micro-circuits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MACOM Technology buying Applied Micro Circuits</a></h4><ul>\n<li>The purchase price of about $8.36 per share consists of $3.25 per share in cash and 0.1089 shares of MACOM (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MTSI\" title=\"MACOM Technology Solutions Holdings, Inc.\">MTSI</a>) for each share of Applied Micro (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMCC\" title=\"Applied Micro Circuits Corporation\">AMCC</a>). That would be a <font color=\"green\">15.4% premium</font> to Friday's close of $7.25.</li>\n<li>The deal value is roughly $770M.</li>\n<li>It's MACOM's intention to divest Applied Micro's Compute business within the first 100 days after closing.</li>\n<li>MACOM expects the deal to be accretive to non-GAAP EPS in the fiscal year ending Sept. 2017.</li>\n<li>A conference call is set for 9 ET.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3225967\" data-linked=\"MACOM Technology buying Applied Micro Circuits\" data-tweet=\"$MTSI $MTSI $AMCC - MACOM Technology buying Applied Micro Circuits https://seekingalpha.com/news/3225967-macom-technology-buying-applied-micro-circuits?source=tweet\" data-url=\"https://seekingalpha.com/news/3225967-macom-technology-buying-applied-micro-circuits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3225964\" data-ts=\"1479730390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCC\" target=\"_blank\">AMCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3225964-applied-micro-circuits-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Micro Circuits halted pending news</a></h4><ul><li>The halt time for <a href='https://seekingalpha.com/symbol/AMCC' title='Applied Micro Circuits Corporation'>AMCC</a> was 7:08 ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3225964\" data-linked=\"Applied Micro Circuits halted pending news\" data-tweet=\"$AMCC - Applied Micro Circuits halted pending news https://seekingalpha.com/news/3225964-applied-micro-circuits-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3225964-applied-micro-circuits-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}